Bowen Therapeutics is equipped to conduct investigator-initiated trials (IITs) at UMASS Worcester. We collaborate with hospitals in both the U.S. and China to assess biological efficacy and safety.

Bowen also provides regulatory services, working closely with regulatory experts to guide biopharmaceutical, nutraceutical, cosmetics, and diagnostics industries through FDA and CFDA approval processes.